Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

National microbiology reference laboratories are central to global health and must be adequately funded, according to a viewpoint article published in The Lancet Digital Health by researchers at Oxford Population Health and the Invasive Respiratory Infection Surveillance (IRIS) Consortium.

Microbiology reference laboratories enable the effective management of infectious diseases by tracking endemic diseases, monitoring rates of antimicrobial resistance, and providing data to assess how well vaccination programmes are working. These laboratories also detect outbreaks and were among the first to identify cases of COVID-19, monitored case numbers in real time, deployed public health responses to the pandemic, advised on policies to protect the public, and informed COVID-19 vaccination programmes.

The article highlights how, despite their key contributions to microbiology and the control of infection diseases worldwide, many laboratories struggle to secure sufficient funding for disease surveillance programmes from government health and science budgets. The authors suggest that, at least in part, this may be because the dedicated work performed by these laboratories is not often flashy and exciting.

However, the authors point out that the work of national reference laboratories is critical to public health, particularly as these labs ensure consistency in data generation and analyses over a long period of time, and the staff working in these labs provide highly specialised knowledge. This is especially important because the long-term nature of effective surveillance allows for the recognition of trends, as well as any deviations from long-term trends that may have an impact on public health. Such deviations might be a change in vaccine coverage, or an increase in antimicrobial-resistance organisms, or indeed the emergence of an outbreak.

Read the full story on the Nuffield Department of Population Health (NDPH) website. 

 

 

Similar stories

Oxford researchers support international response to Bundibugyo virus disease outbreak

Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.

Smoking and drinking exacerbate social inequalities in premature deaths in India

Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Drought linked to 46% increase in sexual violence among adolescents in Southern Africa

Study reveals climate change is increasing risks to child safety.

Oxford launches interdisciplinary centre to advance women's mental health research globally

The University of Oxford is set to launch a new research centre dedicated to women’s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.

New Lancet series shows how thousands of maternal deaths could be prevented each year

Every 12 minutes, somewhere in the world, a woman dies from excessive bleeding after birth (postpartum haemorrhage or PPH). Yet according to a new three-part Lancet Series, led by researchers from the University of Oxford, most of these deaths should never happen.